Transforming Respiratory Care with AI Voice Biomarkers
Experience the Future of Respiratory Health: Our AI Voice Biomarker Application revolutionizes disease diagnosis and tracking, providing accurate and personalized insights for better patient care.
About Us
Ascleb is a biotechnology startup founded by a team with over 25 years of experience in clinical research, healhcare and technology. Recognizing the need for innovative solutions in disease tracking and diagnosis, we embarked on a mission to research and develop new digital biomarkers to revolutionize remote disease monitoring.
​
Our journey began with a groundbreaking clinical trial, where we investigated the feasibility of using voice data for disease tracking and diagnosis. The initial results were promising, demonstrating high accuracy in disease diagnosis. Building on this success, we decided to further validate our findings through a research paper.
​
At Ascleb, we combine our extensive experience in clinical research with the expertise of machine learning professors and medical professionals. This collaboration enables us to create cutting-edge solutions that address the most pressing challenges in healthcare.
​
Our digital biomarkers can be collected through everyday devices such as smartphones and wearables, allowing patients to monitor their health effortlessly. This approach not only improves patient outcomes but also reduces the burden on healthcare systems by enabling remote monitoring and early intervention.
​
Ascleb is committed to pushing the boundaries of healthcare technology. By leveraging the latest advancements in machine learning and clinical research, we aim to make a meaningful impact on the future of healthcare.
Innovative Technology
At Ascleb, our mission is to redefine healthcare through innovative technologies that enable personalized and precise disease tracking and diagnosis. Our current flagship project focuses on utilizing voice data to revolutionize respiratory disease monitoring. In addition, we are actively developing projects that leverage a holistic approach to health monitoring, including tracking body movements and fluids. By combining these diverse data sources, we aim to create digital biomarkers and wearable health devices that can provide early detection and personalized treatment options for a wide range of diseases.
Our commitment to innovation extends beyond respiratory diseases, as we are dedicated to exploring new frontiers in digital health technology. Our research and development efforts are centered around creating solutions that go beyond traditional methods, aiming to provide continuous and non-invasive monitoring for various disease groups. These projects are not only aimed at improving patient outcomes but also at reducing the burden on healthcare systems by enabling remote monitoring and early intervention.
Technology has the potential to improve the quality of healthcare and to make it accessible to more people. Remote monitoring and tracking technologies can revolutionize how we manage health and disease.
